Mood changes and “brain fog” experienced during COVID-19 illness and recovery may stem in part from blood vessel damage and impaired oxygen delivery caused by the disease, suggests a review published in Physiological Reports.
The anticonvulsant ezogabine, also known as retigabine, may offer a new approach to the treatment of depression and anhedonia, suggests a trial published online ahead of print in The American Journal of Psychiatry.
Co-occurrence of adult bipolar disorder (BD) and attention/deficit-hyperactivity disorder (ADHD) is heterogenous and “much higher than expected by chance,” according to a meta-analysis published online in Neuroscience & Biobehavioral Reviews.
Mental health clinicians have utilized telehealth to provide treatment throughout the COVID-19 pandemic, creating a need for alternative plans when technology fails and open conversations with patients to remain effective.
Utilizing technology for telehealth treatment and being unable to meet with patients in person has led many mental health clinicians to experience burnout, causing some of them to stop applying best practices and self-care techniques.
Allison Smith, PhD, senior program administrator for the Louisiana Board of Regents, discusses groups within college populations facing a heightened risk of opioid overdose, crafting policy around naloxone administration, and working with university leaders to make colleges safer.
Stay in the know. Psychiatry and Behavioral Health Learning Network Newsletter